PVI
GBT

Pura Vida Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Pura Vida Investments’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,454
Closed -$462K – 278
2022
Q2 		$462K Sell
14,454
-15,000
-51% -$439K 0.03% 180
2022
Q1 		$1.02M Buy
+29,454
New +$881K 0.03% 185
2017
Q2 		– Sell
-60,598
Closed -$2.23M – 101
2017
Q1 		$2.23M Buy
+60,598
New +$1.53M 0.66% 51

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pura Vida Investments's GBT Position: Q3 2022 in Review

Pura Vida Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 14,454 shares — an estimated $462K sold.

Pura Vida Investments first reported a position in GBT in Q1 2017 and held it in 3 quarters. The position peaked at $2.23M in Q1 2017. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Pura Vida Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Pura Vida Investments sold 14,454 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $462K.
  • Pura Vida Investments first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 3 quarters.
  • Pura Vida Investments's Global Blood Therapeutics, Inc. position peaked at $2.23M in Q1 2017.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.